GenScript
Piscataway, NJ / Nanjing, China
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-29
65.5
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (19)
○ EMA GMP
○ MHRA GMP
Quick Facts: GenScript
- Signal Score
- 65.5/100 (as of 2026-04-29)
- Quality Compliance
- Assessment pending
- Headquarters
- Piscataway, NJ / Nanjing, China
- Modalities
- CAR-T, Cell Therapy, Gene Editing
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About GenScript
BIOSECURE Act exposure via China operations.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCAR-T, Cell Therapy, Gene Editing
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
65.0
Publicly traded — financial transparency
BIOSECURE Act exposure risk
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Publicly traded — financial transparency
BIOSECURE Act exposure risk
Capacity
66.0
2 manufacturing sites
Regulatory milestones (9 articles)
Sites: Piscataway, NJ, Nanjing, China
Source: SEC EDGAR, press monitoring, company profiles
2 manufacturing sites
Recent Press19 articles
2 manufacturing sites
Regulatory milestones (9 articles)
Recent News 19 articles
GenScript Biotech rose more than 5% in early trading as Eli Lilly and Co announced a $7 billion acquisition of an in vivo CAR-T company. - 富途牛牛
GenScript Biotech rose more than 5% in early trading as Eli Lilly and Co announced a $7 billion acquisition of an in vivo CAR-T company. 富途牛牛
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - BioSpace
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era BioSpace
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - Dailyhunt
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era Dailyhunt
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - The Manila Times
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era The Manila Times
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - Thailand Business News
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era Thailand Business News
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - Bolsamania
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era Bolsamania
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - TNGlobal
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era TNGlobal
GenScript reports strong fiscal 2025 results from platform strategy - Vietnam Investment Review - VIR
GenScript reports strong fiscal 2025 results from platform strategy Vietnam Investment Review - VIR
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership - Indian Pharma Post
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership Indian Pharma Post
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth - Bolsamania
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth Bolsamania
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership - Indian Pharma Post
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership Indian Pharma Post
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership - Indian Pharma Post
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership Indian Pharma Post
GenScript opens its first European mRNA production site - Scientist Live
GenScript opens its first European mRNA production site Scientist Live
GenScript opens its first European mRNA production site - Scientist Live
GenScript opens its first European mRNA production site Scientist Live
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub - BioSpace
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub BioSpace
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub - The AI Journal
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub The AI Journal
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub - BeBeez International
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub BeBeez International
GenScript Opens First European mRNA Production Facility In Delft Strengthening Global Biotechnology Platform - BioPharma APAC
GenScript Opens First European mRNA Production Facility In Delft Strengthening Global Biotechnology Platform BioPharma APAC
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub - TNGlobal
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub TNGlobal
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 91.7
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral
RoslinCT
Edinburgh, UK · Hopkinton, MA
Signal Score: 80.2
CAR-T, Cell Therapy, iPSC, Gene Editing
CTMC
Houston, TX
Signal Score: 63.0
CAR-T, Cell Therapy, Gene Editing
Poseida Therapeutics (CDMO)
San Diego, CA
Signal Score: 58.7
CAR-T, Cell Therapy, Gene Editing
Rose BioSolutions
San Francisco, CA (GI Partners parent); operating HQ inherited from Charles River CDMO businesses
Plasmid DNA, AAV, Lentiviral, Adenoviral, CAR-T, Cell Therapy, Gene Editing, Cell Solutions / Starting Materials